SG11201709908QA - Method for quantifying monoclonal antibody - Google Patents

Method for quantifying monoclonal antibody

Info

Publication number
SG11201709908QA
SG11201709908QA SG11201709908QA SG11201709908QA SG11201709908QA SG 11201709908Q A SG11201709908Q A SG 11201709908QA SG 11201709908Q A SG11201709908Q A SG 11201709908QA SG 11201709908Q A SG11201709908Q A SG 11201709908QA SG 11201709908Q A SG11201709908Q A SG 11201709908QA
Authority
SG
Singapore
Prior art keywords
monoclonal antibody
quantifying
quantifying monoclonal
antibody
monoclonal
Prior art date
Application number
SG11201709908QA
Other languages
English (en)
Inventor
Takashi Shimada
Noriko Iwamoto
Akinobu Hamada
Original Assignee
Shimadzu Corp
Nat Cancer Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Corp, Nat Cancer Ct filed Critical Shimadzu Corp
Publication of SG11201709908QA publication Critical patent/SG11201709908QA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21001Chymotrypsin (3.4.21.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21004Trypsin (3.4.21.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G01N2333/7158Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons for chemokines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
SG11201709908QA 2015-06-01 2015-06-01 Method for quantifying monoclonal antibody SG11201709908QA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2015/065806 WO2016194114A1 (ja) 2015-06-01 2015-06-01 モノクローナル抗体の定量方法

Publications (1)

Publication Number Publication Date
SG11201709908QA true SG11201709908QA (en) 2017-12-28

Family

ID=57440329

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201709908QA SG11201709908QA (en) 2015-06-01 2015-06-01 Method for quantifying monoclonal antibody

Country Status (8)

Country Link
US (1) US20180148763A1 (de)
EP (1) EP3306310B1 (de)
JP (1) JP6537605B2 (de)
CN (1) CN107709980B (de)
CA (1) CA2987005C (de)
SG (1) SG11201709908QA (de)
TW (1) TWI675917B (de)
WO (1) WO2016194114A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
WO2015105955A1 (en) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
JP2020513248A (ja) 2016-10-19 2020-05-14 フロデザイン ソニックス, インク.Flodesign Sonics, Inc. 音響による親和性細胞抽出
SG11202003907WA (en) 2017-12-14 2020-05-28 Flodesign Sonics Inc Acoustic transducer drive and controller
WO2019130536A1 (ja) 2017-12-28 2019-07-04 株式会社島津製作所 モノクローナル抗体の簡素化された定量方法
AU2019264349A1 (en) * 2018-04-30 2020-10-15 Phynexus Inc. Qualitative analysis of proteins
CN108680637A (zh) * 2018-05-15 2018-10-19 苏州大学 基于马来酰亚胺衍生物组合的非同位素双标记方法
JPWO2022270126A1 (de) 2021-06-23 2022-12-29

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060014212A1 (en) * 2002-05-10 2006-01-19 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US10151759B2 (en) * 2011-02-10 2018-12-11 Hoffmann-La Roche Inc. Method for the purification of a glycan and/or a glycoconjugate by chromatography using a stationary phase comprising cotton
CA2922372C (en) * 2013-09-09 2018-05-15 Shimadzu Corporation Method for preparing peptide fragments, kit for preparing peptide fragments to be used therein, and analysis method

Also Published As

Publication number Publication date
CA2987005A1 (en) 2016-12-08
WO2016194114A1 (ja) 2016-12-08
JP6537605B2 (ja) 2019-07-03
CN107709980A (zh) 2018-02-16
TWI675917B (zh) 2019-11-01
EP3306310B1 (de) 2020-08-05
JPWO2016194114A1 (ja) 2018-03-22
CA2987005C (en) 2021-11-16
EP3306310A1 (de) 2018-04-11
EP3306310A4 (de) 2018-11-21
TW201643252A (zh) 2016-12-16
CN107709980B (zh) 2020-11-06
US20180148763A1 (en) 2018-05-31

Similar Documents

Publication Publication Date Title
SG11201709908QA (en) Method for quantifying monoclonal antibody
ZA201803874B (en) Humanized anti-cd73 antibodies
HK1246324A1 (zh) 抗pd-l1抗體
HK1257164A1 (zh) 新型抗pd-l1抗體
HK1249114A1 (zh) 針對bcma的單克隆抗體
IL262295B1 (en) Antibodies against pd–l1
IL255727A (en) Novel anti-pd-l1 antibodies
SG11201705252UA (en) Anti-pd-1 monoclonal antibodies and obtaining method thereof
EP3294766C0 (de) Humanized antibody or fragment thereof specific for cd3
HK1258375A1 (zh) 人源化抗-cll-1抗體
SG11201707318PA (en) Method for detecting monoclonal antibody using mass spectrometry
IL247277A0 (en) Monoclonal antibodies against Ebola
IL256579A (en) Human antibodies
EP3175242A4 (de) Quantifizierung monoklonaler antikörpertherapeutika durch lc-ms/ms
SG11201803206YA (en) Method for determining defect region
HK1250046A1 (zh) 抗dkk-1-抗rankl雙特異性抗體化合物
GB201515693D0 (en) Method for antigen detection
PL3371216T3 (pl) Humanizowane przeciwciała anty-BAG3
GB201704115D0 (en) Method of selecting for antibodies
EP3336172A4 (de) Verfahren zur herstellung eines antigenspezifischen monoklonalen antikörpers
EP3362093A4 (de) Heparanase-neutralisierende monoklonale antikörper
GB201511196D0 (en) Monoclonal antibodies
PT3521307T (pt) Método para aquisição de anticorpos
EP3371592C0 (de) Verfahren zur quantifizierung von therapeutischen antikörpern
SI3356398T1 (sl) Postopek za razvijanje monoklonskih protiteles